Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitemolecularpartners...
CategoryBioTech
Phone+41 44 755 77 00
Emailinfo@molecularpar...
Employees
Founded2004

Offices

Zürich, CHE
Wagistrasse 14
Zürich-Schlieren
Zürich, 8952, CHE

People

CEO & Board of Directors
CBO
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Funding

Tags

Molecular Partners

Molecular Partners AG, a biotechnology company, engages in the discovery and development of Designed Ankyrin Repeat Proteins (DARPins) based on the designed repeat protein technology. The company focuses on therapeutic, diagnostic, and biotechnological applications of DARPins. DARPins are binding proteins that show activity against various disease targets, including cell surface receptors, cytokines, proteases, kinases, and viral coat proteins. The company was incorporated in 2004 and is based in Zurich, Switzerland.

Recent Milestones

Videos

Screenshots

Molecular Partners screenshot
Above: Home Page
Uploaded: 12/18/09

Sources

  1. MOLECULAR PARTNERS SECURES $15.56 million IN SERIES A FINANCING (molecularpartners.com) [edit]
  2. Swiss Protein Therapy Co. Molecular Partners Pulls In $44M Series B (fis.dowjones.com) [edit]
  3. Allergan snags rights to retinal disease drug in $420M pact (fiercebiotech.com) [edit]
Edit This Page
Last Edited 4/11/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy